Top Biotech Earnings Reports to Watch This Week

Health and Healthcare

Published: October 21, 2018 10:15 am

Last Updated: January 11, 2020 4:07 pm

Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week. While health care doesn’t seem to be anywhere near the topic of debate ahead of this election season, it has the potential to be hugely affected by whatever party takes power in the United States.

For the other notable earnings this week, check out the Dow Jones industrials earnings and other major earnings previews.

Note that the earnings and revenue estimates may change ahead of the formal reports, and some companies may reschedule reporting dates as well.

Biogen Inc. (NASDAQ: BIIB) is set to report its most recent results on Tuesday. The consensus estimates from Thomson Reuters call for earnings per share (EPS) of $6.78 and $3.33 billion in revenue. Shares were changing hands at $320.41 on Friday’s close. The 52-week range is $249.17 to $388.67.

Alexion Pharmaceuticals Inc. (NASDAQ: ALXN) is scheduled to report its third-quarter results on Wednesday. The consensus estimates are $1.74 in EPS and $1.02 billion in revenue. Shares traded at $125.89 as last week came to a close. The consensus price target is $163.41, and the 52-week trading range is $102.10 to $142.24.

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is set to share its latest quarterly earnings on Thursday. The consensus estimates call for a net loss of $0.21 per share on $366.93 million in revenue. Shares were at $103.22 on Friday’s close, in a 52-week range of $75.81 to $106.74. The consensus price target is $120.05.

Bristol-Myers Squibb Co. (NYSE: BMY) is expected to reveal its third-quarter results on Thursday. The consensus forecast calls for $0.91 in EPS, as well as $5.72 billion in revenue. The stock ended last week at $54.30 per share. The consensus price target is $61.59, and the 52-week range is $49.96 to $70.05.

Celgene Corp. (NASDAQ: CELG) also will share its latest quarterly earnings on Thursday. The consensus estimates call for $2.34 in EPS and $1.74 billion in revenue. Shares were at $99.62 as Friday’s trading ended, in a 52-week range of $95.45 to $119.29. The consensus price target is $128.22.

And Gilead Sciences Inc. (NASDAQ: GILD) is expected to reveal its third-quarter results on Thursday as well. The consensus forecast calls for $1.63 in EPS, as well as $5.37 billion in revenue. The stock ended last week at $73.27 per share. The consensus price target is $87.91, and the 52-week trading range is $64.27 to $89.54.

ALSO READ: Jefferies Out With 5 Biotech Stocks Under $10 With Gigantic Upside Potential

The Average American Has No Idea How Much Money You Can Make Today (Sponsor)

The last few years made people forget how much banks and CD’s can pay. Meanwhile, interest rates have spiked and many can afford to pay you much more, but most are keeping yields low and hoping you won’t notice.

But there is good news. To win qualified customers, some accounts are paying almost 10x the national average! That’s an incredible way to keep your money safe and earn more at the same time. Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 3.80% with a Checking & Savings Account today Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.

Click here to see how much more you could be earning on your savings today. It takes just a few minutes to open an account to make your money work for you.

Our top pick for high yield savings accounts includes other benefits as well. You can earn up to 4.00% with a Checking & Savings Account from Sofi. Sign up and get up to $300 with direct deposit. No account fees. FDIC Insured.

¹https://www.fdic.gov/national-rates-and-rate-caps